PROMOMED expands the geography of its presence: The company has opened an international division in China
27.07.2026
27.07.2026
The production of unique domestic veterinary drugs was established at the Saransk Biochemist plant, part of the Promomed group of companies. The company's capabilities to provide the Russian market with high-demand medicines for animals were evaluated by the Minister of Agriculture of the Russian Federation Oksana Lut, the Minister of Labor and Social Protection of the Russian Federation Anton Kotyakov and the head of the Republic of Mordovia Artyom Zdunov, visiting the production sites of the plant.

Oksana Lut and Anton Kotyakov visited the production sites of the plant. / Promomed Press Service
The products of one of the leading Russian biopharmaceutical companies, which has successfully implemented import substitution of vital medical products and the development of its own pharmaceutical innovations, are well known to Russians. And recently, they started creating veterinary products here.
Today, the company already produces a wide range of veterinary medicines, including antiparasitic, antibacterial, painkillers and cardiological products for pets. The development was carried out in close cooperation with the leading scientific organizations of the country. Among them are the All-Russian State Center for Quality and Standardization of Medicines for Animals and Feed, Don State Technical University, NGO "House of Pharmacy".
The delegation's visit began with an inspection of the workshop for the production of active pharmaceutical substances (APIs) or active substances. The company's motto is: from idea to molecule, from molecule to finished dosage form. Our own synthesis of pharmaceutical substances allows us to guarantee a full production cycle in the country and eliminate dependence on imported supplies.
Then the guests visited a separate workshop, where the production of an innovative veterinary medicine to protect pets from ticks has been established. This is the only fluralaner-based medicinal product on the domestic market, produced under an official license for the use of patented inventions. It is manufactured using a technology that has no analogues in the country. The production line was developed and set up by a team of Russian technologists and engineers.
At the end of the visit, Oksana Lut got acquainted with the production of a cardiological veterinary drug on a unique automatic pill production line.
"We are consistently developing the strengths of our region, including pharmaceuticals and biotechnologies," said Artyom Zdunov. - Now Mordovia is engaged in innovations in veterinary medicine.
Many years of experience in medicine, scientific developments and advanced technologies have allowed domestic manufacturers to create effective and safe veterinary medicines in a short time to maintain the health of domestic and farm animals. The company's unique R&D center has more than 500 employees and provides a full development cycle: from the search for a molecule to transfer to production, research (preclinical and clinical) and state registration. Effective monitoring and control systems for raw materials, manufacturing processes, and finished medicines are used at all stages to ensure high product quality.
Over the next year, the company plans to launch more than 25 types of medicines for veterinary use. Ten of them are included in the List of veterinary drugs necessary for the market.
"The successful implementation of modern production technologies allows us to scale the production of high-quality veterinary drugs of a new generation," said Peter Bely, Chairman of the company's Board of Directors. - Thus, we strengthen the position of the domestic veterinary pharmacy and contribute to the formation of a reliable system for the production of medicines for animals.
SourcesStay informed
Stay informed
Get the most interesting news and publications first!
Sent successfully!
Press office
To request a press release or interview, please contact our press office